News

AddToAny

Google+ Facebook Twitter Twitter

How blood cancer "recharges"

A new study has uncovered how blood cancer “steals” parts of surrounding healthy bone marrow cells in order to thrive.

The researchers found healthy bone marrow stromal cells were made to transfer their power-generating mitochondria to neighbouring cancer cells, effectively “recharging” the acute myeloid leukaemia (AML) and supporting the leukaemia to grow.

AML has been found to act in a parasitic way by first generating oxygen-deprived conditions in the bone marrow, which then stimulates the transfer of healthy mitochondria from the non-cancerous cells to the leukaemia cells.

The study, published in Blood, also identified how and why the mitochondria are transferred and discusses the potential impact this could have on future treatment and study of cancer.

Study author Stuart Rushworth said: “Our results provide a first in the study of cancer mitochondrial transfer mechanism. We have clearly shown that the cancer cell itself drives transfer by increasing oxidative stress in the neighbouring non-malignant donor cells.”

bit.ly/BS_NovNews3

Related Articles

girl computer_CREDIT_shutterstock-58872785

Gamification in biomedical science education

Senior Lecturer in Biomedical Science Jen May outlines the successful implementation of scenario-based learning software.

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Top